A groundbreaking shift in our drug policy has taken place, as the government permit the legalization of psilocybin hallucinogens for therapeutic treatment. Previously, these substances were heavily restricted, but a increasing body of research suggests they could offer benefits for psychological illnesses like depression. The new policy represents